MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
Coronado Biosciences (Nasdaq: CNDO)
Parents
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
*Industry: New York City
Children
Company is developing immunotherapy approaches to treating acute myeloid leukemia, inflammatory bowel disease, multiple sclerosis, and other autoimmune diseases.
Coronado Biosciences Pulls in $25.8 Million (2011)
Coronado names new CEO, indicates it wants a new drug (2013)
Coronado stock up despite larger-than-expected loss in Q2 (2013)
Harlan Weisman, who has been a director at Coronado Biosciences since 2009 and CEO since December 2012, has left the company(2013).
It previously raised $21.6 million in November 2010.
Replaced by Lindsay Rosenwald, formerly a director at the company.(2013)